Multicenter, open-label, randomised, haloperidol-controlled study to evaluate Seroquel [quetiapine] as mono-therapy in the treatment of agitated symptoms in the patients with acute episode of schizophrenia
Phase of Trial: Phase III
Latest Information Update: 21 Aug 2012
At a glance
- Drugs Haloperidol; Quetiapine
- Indications Schizophrenia
- Focus Therapeutic Use
- 21 Aug 2012 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 02 Apr 2008 New trial record.